Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.

Figueroa CE, Bose S.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1046-55. doi: 10.1016/j.ejpb.2013.07.015. Epub 2013 Jul 31.

PMID:
23916460
2.

Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.

Salazar J, Müller RH, Möschwitzer JP.

Eur J Pharm Sci. 2013 Jul 16;49(4):565-77. doi: 10.1016/j.ejps.2013.04.003. Epub 2013 Apr 12.

PMID:
23587645
3.

Application of spray granulation for conversion of a nanosuspension into a dry powder form.

Bose S, Schenck D, Ghosh I, Hollywood A, Maulit E, Ruegger C.

Eur J Pharm Sci. 2012 Aug 30;47(1):35-43. doi: 10.1016/j.ejps.2012.04.020. Epub 2012 May 4.

PMID:
22565066
4.

Optimization and dissolution performance of spray-dried naproxen nano-crystals.

Kumar S, Shen J, Zolnik B, Sadrieh N, Burgess DJ.

Int J Pharm. 2015;486(1-2):159-66. doi: 10.1016/j.ijpharm.2015.03.047. Epub 2015 Mar 23.

PMID:
25814034
5.

Conversion of nanosuspensions into dry powders by spray drying: a case study.

Chaubal MV, Popescu C.

Pharm Res. 2008 Oct;25(10):2302-8. doi: 10.1007/s11095-008-9625-0. Epub 2008 May 29.

PMID:
18509597
6.

Preparation and solidification of redispersible nanosuspensions.

Zhang X, Guan J, Ni R, Li LC, Mao S.

J Pharm Sci. 2014 Jul;103(7):2166-2176. doi: 10.1002/jps.24015. Epub 2014 May 19.

PMID:
24840928
7.

In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.

Kumar S, Jog R, Shen J, Zolnik B, Sadrieh N, Burgess DJ.

J Pharm Sci. 2015 Sep;104(9):3018-28. doi: 10.1002/jps.24155. Epub 2014 Sep 5.

PMID:
25195539
8.

Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.

Niwa T, Miura S, Danjo K.

Pharm Res. 2011 Sep;28(9):2339-49. doi: 10.1007/s11095-011-0465-y. Epub 2011 May 28.

PMID:
21626059
9.

Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.

Kumar S, Xu X, Gokhale R, Burgess DJ.

Int J Pharm. 2014 Apr 10;464(1-2):34-45. doi: 10.1016/j.ijpharm.2014.01.013. Epub 2014 Jan 19.

PMID:
24447788
10.

Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: influence of drug hydrophobicity on nanoparticle reagglomeration.

Lv Q, Li X, Shen B, Xu H, Shen C, Dai L, Bai J, Yuan H, Han J.

Int J Nanomedicine. 2014 Jan 15;9:505-15. doi: 10.2147/IJN.S56215. eCollection 2014.

11.

Formulation and drying of miconazole and itraconazole nanosuspensions.

Cerdeira AM, Mazzotti M, Gander B.

Int J Pharm. 2013 Feb 25;443(1-2):209-20. doi: 10.1016/j.ijpharm.2012.11.044. Epub 2013 Jan 4.

PMID:
23291552
12.

Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.

Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, Iqbal Z, Bilgili E, Davé RN.

Int J Pharm. 2012 Feb 28;423(2):496-508. doi: 10.1016/j.ijpharm.2011.12.001. Epub 2011 Dec 9.

PMID:
22178619
13.

Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads.

Kayaert P, Anné M, Van den Mooter G.

J Pharm Pharmacol. 2011 Nov;63(11):1446-53. doi: 10.1111/j.2042-7158.2011.01351.x. Epub 2011 Sep 27.

PMID:
21988425
14.

Clay as a matrix former for spray drying of drug nanosuspensions.

Dong Y, Ng WK, Hu J, Shen S, Tan RB.

Int J Pharm. 2014 Apr 25;465(1-2):83-9. doi: 10.1016/j.ijpharm.2014.02.025. Epub 2014 Feb 19.

PMID:
24560641
15.

Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.

Freag MS, Elnaggar YS, Abdallah OY.

Int J Pharm. 2013 Sep 15;454(1):462-71. doi: 10.1016/j.ijpharm.2013.06.039. Epub 2013 Jul 3.

PMID:
23830765
16.

Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency.

Liu T, Müller RH, Möschwitzer JP.

Drug Dev Ind Pharm. 2018 Feb;44(2):233-242. doi: 10.1080/03639045.2017.1386207. Epub 2017 Oct 17.

PMID:
28956456
17.

Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.

Kumar S, Jog R, Shen J, Zolnik B, Sadrieh N, Burgess DJ.

Pharm Res. 2015 May;32(5):1694-703. doi: 10.1007/s11095-014-1567-0. Epub 2014 Nov 11.

PMID:
25385690
18.

Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.

Hu J, Ng WK, Dong Y, Shen S, Tan RB.

Int J Pharm. 2011 Feb 14;404(1-2):198-204. doi: 10.1016/j.ijpharm.2010.10.055. Epub 2010 Nov 5.

PMID:
21056643
19.

Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.

Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P, Van den Mooter G.

Eur J Pharm Sci. 2008 Sep 2;35(1-2):127-35. doi: 10.1016/j.ejps.2008.06.009. Epub 2008 Jul 3.

PMID:
18644441
20.

Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.

Azad M, Arteaga C, Abdelmalek B, Davé R, Bilgili E.

Drug Dev Ind Pharm. 2015;41(10):1617-31. doi: 10.3109/03639045.2014.976574. Epub 2014 Oct 27.

PMID:
25347144

Supplemental Content

Support Center